DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
DGAP-Ad-hoc: Fresenius Medical Care AG & Co. KGaA / Key word(s): Change in Forecast/Preliminary Results
In the second quarter Fresenius Medical Care experienced increasing different headwinds that are now expected to negatively impact the Company´s earnings development in the second half of FY 2022 to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected by increased wage inflation and worsened staff shortages resulting in capacity constraints in North American Health Care Services. Additionally, the worsening of the macroeconomic environment is expected to result in higher inflation and disruptions in supply chain.
Against this backdrop, Fresenius Medical Care now anticipates for FY 2022, in constant currency and before special items, revenue to grow at the low end of the previously guided low to mid-single digit percentage range and now assumes net income (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) to decline around a high teens percentage range. Due to uncertainties of the U.S. labor market and macro-economic inflationary environment, which are assumed to be temporary, Fresenius Medical Care withdraws 2025 targets of compounded annual average increases in the mid-single-digit percentage range for revenue and in the high-single-digit percentage range for net income (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA). Contact: Dr. Dominik Heger EVP | Head of Investor Relations, Strategic Development & Communications [email protected] P. +49 6172 609 2601
27-Jul-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Fresenius Medical Care AG & Co. KGaA |
Else-Kröner-Straße 1 | |
61352 Bad Homburg | |
Germany | |
Phone: | +49 (0) 6172- 609 2525 |
Fax: | +49 (0) 6172- 609 2301 |
E-mail: | [email protected] |
Internet: | www.freseniusmedicalcare.com |
ISIN: | DE0005785802 |
WKN: | 578580 |
Indices: | DAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange |
EQS News ID: | 1407557 |
End of Announcement | DGAP News Service |
|
1407557 27-Jul-2022 CET/CEST
Fresenius Medical Care AG & Co KGaA ST Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Fresenius Medical Care AG & Co KGaA ST stock is not clear.
With a target price of 50 € there is a positive potential of 34.12% for Fresenius Medical Care AG & Co KGaA ST compared to the current price of 37.28 €.